Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12R - Indexing scheme associated with subclasses , relating to micro-organisms › C12R 1 - Micro-organisms
Patents for C12R 1 - Micro-organisms (92,025)
11/2000
11/22/2000EP1053335A1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/22/2000EP1053331A2 A novel fungal protein critical for expression of fungal proteins
11/22/2000EP1053329A1 RECOMBINANT LIPIDATED PsaA PROTEIN, METHODS OF PREPARATION AND USE
11/22/2000EP0871885A4 Attachment enhanced 293 cells
11/22/2000EP0776369A4 Dna sequences encoding porcine pancreatic carboxypeptidase b
11/22/2000EP0703988B1 Mesothelial cell gene therapy
11/22/2000EP0601005B1 Detergent enzymes
11/22/2000EP0550696B1 Purified thermostable nucleic acid polymerase enzyme from thermosipho africanus
11/22/2000CN1274388A Mutated barnase gene and plant transformed by same
11/22/2000CN1274259A Hypersensitive response elicitor from i(pseudomonas syringae) and its use
11/22/2000CN1273839A Transfer and modification of intestinalprobiotics fermentation culture medium to natural medicine
11/22/2000CN1058753C Process for producing polysacharides
11/22/2000CN1058721C Mehtod for prepn. of xylitol
11/21/2000US6150586 Nucleotide sequences; transgenic plants with modified fatty acid production capacity
11/21/2000US6150508 Monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen
11/21/2000US6150472 Block copolymers crosslinked to polysaccharide with cellulose derivatiiives, polyacrylic acid, polyethers and polyethylenimine,
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150169 Inserting a coding sequence into a target endogenous gene in a mouse embryonic stem cell genome by transforming with vector having specific dna construct and allowing homologous recombination
11/21/2000US6150165 Polynucleotide which encodes a delta-endotoxin active against coleopteran pests; biological pest control; transgenic plants; treatment of plants and seeds
11/21/2000US6150153 Thermostable trehalose-releasing enzyme
11/21/2000US6150150 Human brain phosphodiesterase
11/21/2000US6150149 Nucleotide and amino acid sequence; recombinant production; for use in breeding technology of basidiomycetes fungi and plants
11/21/2000US6150144 Preparing fatty acid compound; culturing mutant microorganism which produces arachidonic acid and in which desaturase actvity is reduced and chain elongation has been amplified, recover fatty acid compound
11/21/2000US6150140 Process for the biotransformation of colchicinoid compounds into the corresponding 3-glycosyl derivatives
11/21/2000US6150139 Preparing bactericide; culturing cells, separating the supernatant, separate bateriocin from supernatant, recover bacteriocin
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6150132 Vector coding polypeptides for the diagnosis and treatment of allergies and atherosclerosis; for the prevention of graft ejection and injuries to stem cell caused by anticarcinogenic agents
11/21/2000US6150116 Transcription factor DP-1 antibody
11/21/2000US6150109 Lipophilic quenching of viral inactivating agents
11/21/2000US6150099 Detecting modulators of transcription factors; incubating transcription factor and modulator in solution, monitor the level of gene expression
11/21/2000US6150093 Unique associated Kaposi's sarcoma virus sequences and uses thereof
11/21/2000US6150087 Non-hepatitis a or b virus polypeptide which is capable of illiciting immune response with hepatitus virus antibodies, for the treatment of and prevention of viral infections
11/21/2000US6150081 Nucleated with peptizer
11/21/2000US6149936 DNA expression vectors for the use in the gene therapeutic treatment of vascular disorders
11/21/2000CA2166691C Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development
11/21/2000CA2051090C Cephalosporin c acylase
11/21/2000CA1341143C Purified thermostable enzyme
11/16/2000WO2000068428A1 Methods for producing modified nucleic acid molecules
11/16/2000WO2000068418A1 Assays for nucleoside diphosphates and triphospates
11/16/2000WO2000068413A1 Halo- or hydroxy-substituted nocathiacin antibiotics
11/16/2000WO2000068408A1 Method for the selective esterification of polyoles
11/16/2000WO2000068407A1 Clostridium strains which produce ethanol from substrate-containing gases
11/16/2000WO2000068401A1 Recombinant penicillium funiculosum for homologous and heterologous protein production
11/16/2000WO2000068396A2 Bacillus circulans xylanase mutants
11/16/2000WO2000068394A1 Epoxide hydrolases of aspergillus origin
11/16/2000WO2000068379A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000WO2000068376A1 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same
11/16/2000WO2000068261A2 Attenuated microorganisms for the treatment of infection
11/16/2000WO2000067792A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000WO2000067700A2 Recombinant vaccine against botulinum neurotoxin
11/16/2000WO2000067696A2 Lactic acid bacteria with anxiolytic properties and uses thereof
11/16/2000WO2000042204A3 Trans-acting factors in yeast
11/16/2000WO2000042168A3 Bifidobacterium in the treatment of inflammatory disease
11/16/2000WO2000024907A3 Library of novel "unnatural" natural products
11/16/2000WO2000022439A3 Method and substances for diagnosis and therapy of sepsis and sepsis-like systemic infections
11/16/2000WO2000007432A9 Biodegradable high oxidative stability oils
11/16/2000WO2000006717A9 Improved transformation efficiency in phage display through modification of a coat protein
11/16/2000WO2000001713A3 Diacylglycerol acyl transferase proteins
11/16/2000DE19949579C1 Microorganism with deregulated cysteine metabolism, useful for high-level production of cysteine and its derivatives, has increased activity of the CysB transcription regulator
11/16/2000DE19921710A1 Biomelanin Biomelanin
11/16/2000CA2373631A1 Monoclonal antibody directed against cells of human renal cell carcinoma
11/16/2000CA2373135A1 Novel thermostable alkaliphilic xylanase
11/16/2000CA2372983A1 Recombinant penicillium funiculosum for homologous and heterologous protein production
11/16/2000CA2372961A1 Halo- or hydroxy-substituted nocathiacin antibiotics
11/16/2000CA2372699A1 Methods for treating tumors using antiangiogenic compounds
11/16/2000CA2371279A1 Recombinant vaccine against botulinum neurotoxin
11/15/2000EP1052290A2 Biomelanin
11/15/2000EP1052286A2 Growth hormone and growth hormone releasing hormone compositions
11/15/2000EP1051620A1 Variable heavy chain and variable light chain regions of antibodies to human platelet glycoprotein ib alpha
11/15/2000EP1051506A1 Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugates vaccines
11/15/2000EP1051501A1 Nucleic acid molecule encoding a cephalosporin acetylesterase
11/15/2000EP1051489A2 Compounds for therapy and diagnosis of lung cancer and methods for their use
11/15/2000EP0832191A4 Recombinant viral nucleic acids
11/15/2000EP0765343B1 MONOCLONAL ANTIBODY ACTIVE AGAINST CD44v6
11/15/2000CN1273607A Process for biotransformation of colchicone compounds into the correspoonding 3-o-glycosyl derivatives
11/15/2000CN1273603A Attenuated respiratory syncytial viruses
11/15/2000CN1273601A Enzymes mixture
11/15/2000CN1273276A Microbiological inversion of 2-methyl-quinoxaline
11/15/2000CN1058524C Heat tolerant phytases
11/15/2000CN1058523C Genes for butyrobetaine/crotonobetaine-L-carnitine metabolism and their use for microbiological production of L-carine
11/14/2000US6147282 Method of controlling the fertility of a plant
11/14/2000US6147190 Protein associated with activating cell propagation; for the treatment of a nervous system disorders; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147050 5-lipoxygenase-activating protein II
11/14/2000US6146903 Method for determination of water treatment polymers
11/14/2000US6146887 DNA expression vectors for use in the gene therapeutic treatment of vascular disorders
11/14/2000US6146871 Process for modifying the enzyme 7β-(4-carboxybutanamide) cephalosporinacylase and purifying said enzyme in a single chromatographic step
11/14/2000US6146864 Nucleotide and amino acid sequence from fusarium venenatum; for recombinant production of enzyme
11/14/2000US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase
11/14/2000US6146862 Thermostable diaphorase gene
11/14/2000US6146861 Producing amidase or nitrilase by culturing rhodococcus rhodochrous strain ncimb 40756 or mutant in continuous culture in medium having limited carbon source of either amide or precursor or nitrile or precursor, recovering enzyme
11/14/2000US6146857 Method for producing glycogens for use in cosmetics by culturing yeast cells in two phases
11/14/2000US6146846 Primosome protein a of streptococcus pneumoniae
11/14/2000US6146635 System for the expression of heterologous antigens as fusion proteins
11/14/2000US6146634 Proteins with urease activity
11/14/2000US6146626 Mixtures of purified enzymes from clostridium histolyticum, comprising collagenase with hexapeptide as a substrate, collagenase using azocoll as substrate and elastase, used as wound healing agent
11/14/2000CA2153103C Process for lysing mycobacteria
11/14/2000CA2074839C Modified factor vii anticoagulant proteins
11/14/2000CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof
11/09/2000WO2000066791A1 Neisseria genomic sequences and methods of their use
11/09/2000WO2000066789A2 Polynucleotide matrix-based method of identifying microorganisms
1 ... 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 ... 921